Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Darlington
Observed names:
Darlington, Kate,
K Darlington,
K. Darlington
Observed institutions:
University of Siena,
Glan Clwyd Hospital,
University of Bonn,
University Hospital Bonn,
Royal Alexandra Hospital,
Royal Albert Edward Infirmary
show all 6
OpenAlex ID:
A5064197862
Mapping the human genetic architecture of COVID-19
2021
·
COVID-19 Host Genetics Initiative
, COVID-19 Host Genetics InitiativeLeadership
, et al.
·
Nature
·
983
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022
·
Athanasios Kousathanas
, Erola Pairo-Castineira
, et al.
·
Nature
·
326
PDF
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
224
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
A second update on mapping the human genetic architecture of COVID-19
2023
·
The COVID-19 Host Genetics Initiative
, Leadership
, et al.
·
Nature
·
118
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
2021
·
Chiara Fallerini
, Nicola Picchiotti
, et al.
·
Human Genetics
·
37
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
2024
·
Jannik Boos
, Caspar I. van der Made
, et al.
·
Human Genetics and Genomics Advances
·
12
PDF
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
9
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Mapping the human genetic architecture of COVID-19
2021
·
Niemi, Mari E. K.
, Karjalainen, Juha
, et al.
·
Research at the University of Copenhagen (University of Copenhagen)
·
5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Show more works
View as search
Works count:
19
Citation count:
3,947
H-index:
13
I10-index:
15
Year
Topic
Type
